Dicot Pharma AB (STO:DICOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.299
-0.012 (-3.71%)
At close: Feb 27, 2026
2.75%
Market Cap 599.79M
Revenue (ttm) n/a
Net Income (ttm) -80.20M
Shares Out 2.01B
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,970,464
Average Volume 6,309,470
Open 0.311
Previous Close 0.310
Day's Range 0.298 - 0.316
52-Week Range 0.225 - 1.180
Beta 1.78
RSI 44.69
Earnings Date Feb 18, 2026

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden. [Read more]

Sector Healthcare
Founded 2015
Employees 4
Stock Exchange Nasdaq Stockholm
Ticker Symbol DICOT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.